# A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.

> **NCT00234455** · PHASE2 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 86 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** drug eluting-stent
- **DEVICE:** drug-eluting stent

## Key facts

- **NCT ID:** NCT00234455
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2002-10
- **Final completion:** 2007-04
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2008-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234455, "A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00234455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*